Concepedia

Gustavo Nogareda

GN

Statistics

Publications

6

Citations

898

H-Index

6

Active since

2003

Affiliations

St. Michael's Hospital(Current)

Auckland City Hospital

Instituto Cardiovascular de Rosario

Canadian VIGOUR Centre

Leiden University Medical Center

Gustavo Nogareda is an author at St. Michael's Hospital specializing in medicine, clinical cardiology, and lipid-lowering therapy.

Publications per year

2003–2022

6

Publications

6

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Frequency of and Inappropriate Treatment of Misdiagnosis of Acute Aortic Dissection

Mark S. Hansen, Gustavo Nogareda, Stuart J. Hutchison · The American Journal of Cardiology · 2007 · 243 citations

, , +14

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 38 citations · Full text

, , +17

1–5 of 6